Back to discover
Disease

Epileptic Syndromes

Late-stage therapeutic developmentEmerging research
1
Publications
1
Clinical trials
2022
Latest publication
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

No activity recorded in this window. Try a wider timeframe.

Clinical trials

1 sponsors · 0 new · 0 completed in the last 12 months (net +0)

The current development programme across all trial phases.

Clinical programme
1
All trials
0
Active
1
Late-stage
0
Completed

Research activity

1 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Major themes3
  • Epilepsy1
  • Epilepsy, Generalized1
  • Epileptic Syndromes1
Leading journals1
  • Epilepsia1
Leading researchers8
  • Auvin S1
  • Cross JH1
  • Galicchio S1
  • Hirsch E1
  • Moshé SL1
  • Nabbout R1
  • Perucca E1
  • Pressler R1
Affiliations (unnormalised)6
  • Aga Khan University1
  • Albert Einstein College of Medicine1
  • Austin Health and Royal Children's Hospital1
  • Bambino Gesu' Children's Hospital1
  • Clinical Neuroscience1
  • Department of Clinical Neurophysiology1

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

EPILEPTIC SEIZURES that are of similar type and age of onset and have other similar features (e.g., clinical course, EEG findings, genetic association and neuropathology).

References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.